ENTITY

Novo Nordisk (NVO US)

93
Analysis
Health Care • Denmark
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
more
•07 Jun 2023 10:28•Broker

Today's Dominant Ideas

The SET Index is expected to move sideways down, with the support at 1,521/1,517 points and the resistance at 1,541/1,545 points. Key issues...

Logo
88 Views
Share
x